Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
22 "antiviral"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review
The Role of Extracellular Vesicles in Pandemic Viral Infections
Woosung Shim, Anjae Lee, Jung-Hyun Lee
J. Microbiol. 2024;62(6):419-427.   Published online June 25, 2024
DOI: https://doi.org/10.1007/s12275-024-00144-x
  • 89 View
  • 0 Download
  • 2 Web of Science
  • 1 Crossref
AbstractAbstract
Extracellular vesicles (EVs), of diverse origin and content, are membranous structures secreted by a broad range of cell types. Recent advances in molecular biology have highlighted the pivotal role of EVs in mediating intercellular communication, facilitated by their ability to transport a diverse range of biomolecules, including proteins, lipids, DNA, RNA and metabolites. A striking feature of EVs is their ability to exert dual effects during viral infections, involving both proviral and antiviral effects. This review explores the dual roles of EVs, particularly in the context of pandemic viruses such as HIV-1 and SARS-CoV-2. On the one hand, EVs can enhance viral replication and exacerbate pathogenesis by transferring viral components to susceptible cells. On the other hand, they have intrinsic antiviral properties, including activation of immune responses and direct inhibition of viral infection. By exploring these contrasting functions, our review emphasizes the complexity of EV-mediated interactions in viral pathogenesis and highlights their potential as targets for therapeutic intervention. The insights obtained from investigating EVs in the context of HIV-1 and SARS-CoV-2 provide a deeper understanding of viral mechanisms and pathologies, and offer a new perspective on managing and mitigating the impact of these global health challenges.

Citations

Citations to this article as recorded by  
  • Differential Impact of Spike Protein Mutations on SARS-CoV-2 Infectivity and Immune Evasion: Insights from Delta and Kappa Variants
    Tae-Hun Kim, Sojung Bae, Jinjong Myoung
    Journal of Microbiology and Biotechnology.2024; 34(12): 2506.     CrossRef
Journal Articles
The Regulation of Phosphorus Release by Penicillium chrysogenum in Different Phosphate via the TCA Cycle and Mycelial Morphology
Liyan Wang , Da Tian , Xiaoru Zhang , Mingxue Han , Xiaohui Cheng , Xinxin Ye , Chaochun Zhang , Hongjian Gao , Zhen Li
J. Microbiol. 2023;61(8):765-775.   Published online September 4, 2023
DOI: https://doi.org/10.1007/s12275-023-00072-2
  • 45 View
  • 0 Download
  • 2 Web of Science
AbstractAbstract
Phosphate-solubilizing fungi (PSF) efficiently dissolve insoluble phosphates through the production of organic acids. This study investigates the mechanisms of organic acid secretion by PSF, specifically Penicillium chrysogenum, under tricalcium phosphate ( Ca3(PO4)2, Ca–P) and ferric phosphate ( FePO4, Fe–P) conditions. Penicillium chrysogenum exhibited higher phosphorus (P) release efficiency from Ca-P (693.6 mg/L) than from Fe–P (162.6 mg/L). However, Fe–P significantly enhanced oxalic acid (1193.7 mg/L) and citric acid (227.7 mg/L) production by Penicillium chrysogenum compared with Ca–P (905.7 and 3.5 mg/L, respectively). The presence of Fe–P upregulated the expression of genes and activity of enzymes related to the tricarboxylic acid cycle, including pyruvate dehydrogenase and citrate synthase. Additionally, Fe–P upregulated the expression of chitinase and endoglucanase genes, inducing a transformation of Penicillium chrysogenum mycelial morphology from pellet to filamentous. The filamentous morphology exhibited higher efficiency in oxalic acid secretion and P release from Fe–P and Ca–P. Compared with pellet morphology, filamentous morphology enhanced P release capacity by > 40% and > 18% in Ca–P and Fe–P, respectively. This study explored the strategies employed by PSF to improve the dissolution of different insoluble phosphates.
Comparative study of the geographical spread of genogroup II porcine norovirus and human norovirus
Eung Seo Koo , Yong Seok Jeong
J. Microbiol. 2021;59(7):644-650.   Published online July 1, 2021
DOI: https://doi.org/10.1007/s12275-021-1218-1
  • 47 View
  • 0 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract
Livestock pigs and porcine norovirus could be candidate tools for future studies on the geographic isolation of norovirus. In this study, we provide the first evidence for geographic isolation of the host as a determinant of the distribution of subgenotypes of the porcine norovirus genogroup II (GII) genotype 11. Environmental water samples were collected from peri-urban streams and estuaries in South Korea between 2014 and 2020. In total, 488 GII region C sequences of norovirus open reading frame 2 were isolated. A total of 14 genotypes were detected, two of which (GII.11 and GII.18) corresponded to porcine norovirus. Five human norovirus genotypes (GII.2, GII.3, GII.4, GII.6, and GII.17) and one porcine norovirus genotype (GII.11) comprised the subgenotypes. Integrated analysis of seasonal and geographical factors revealed that the possibility of the co-emergence of different GII.11 subgenotypes in the same province was lower than that of human norovirus subgenotypes in the same province. Additional algorithms designed to eliminate potential biases further supported the estimated restricted geographical spread of the GII.11 subgenotypes. Fecal contamination source tracking revealed low detection rates of porcine norovirus in the absence of upstream pig farms. These results suggest that a one-sided viral transmission route, mainly dependent on indirect contact owing to the limited chance of direct contact between geographically separated livestock pig populations, may be responsible for the restricted geographical spread of the GII.11 subgenotypes.

Citations

Citations to this article as recorded by  
  • Swine Norovirus: Past, Present, and Future
    Lara Cavicchio, Andrea Laconi, Alessandra Piccirillo, Maria Serena Beato
    Viruses.2022; 14(3): 537.     CrossRef
Potency of Phlebia species of white rot fungi for the aerobic degradation, transformation and mineralization of lindane
Pengfei Xiao , Ryuichiro Kondo
J. Microbiol. 2020;58(5):395-404.   Published online March 28, 2020
DOI: https://doi.org/10.1007/s12275-020-9492-x
  • 57 View
  • 0 Download
  • 12 Web of Science
  • 11 Crossref
AbstractAbstract
The widespread use of the organochlorine insecticide lindane in the world has caused serious environmental problems. The main purpose of this paper is to investigate the potency of several Phlebia species of white rot fungi to degrade, transform and mineralize lindane, and to provide the feasibility of using white rot fungi for bioremediation at contaminated sites. Based on tolerance experiment results, Phlebia brevispora and Phlebia lindtneri had the highest tolerance to lindane and were screened by degradation tests. After 25 days of incubation, P. brevispora and P. lindtneri degraded 87.2 and 73.3% of lindane in low nitrogen medium and 75.8 and 64.9% of lindane in high nitrogen medium, respectively. Several unreported hydroxylation metabolites, including monohydroxylated, dehydroxylated, and trihydroxylated products, were detected and identified by GC/MS as metabolites of lindane. More than 10% of [14C] lindane was mineralized to 14CO2 by two fungi after 60 days of incubation, and the mineralization was slightly promoted by the addition of glucose. Additionally, the degradation of lindane and the formation of metabolites were efficiently inhibited by piperonyl butoxide, demonstrating that cytochrome P450 enzymes are involved in the fungal transformation of lindane. The present study showed that P. brevispora and P. lindtneri were efficient degraders of lindane; hence, they can be applied in the bioremediation process of lindane-contaminated sites.

Citations

Citations to this article as recorded by  
  • The role and mechanisms of microbes in dichlorodiphenyltrichloroethane (DDT) and its residues bioremediation
    Girma Ebsa, Birhanu Gizaw, Mesele Admassie, Tizazu Degu, Tesfaye Alemu
    Biotechnology Reports.2024; 42: e00835.     CrossRef
  • New frontiers of soil fungal microbiome and its application for biotechnology in agriculture
    Maicon S. N. dos Santos, Lissara P. Ody, Bruno D. Kerber, Beatriz A. Araujo, Carolina E. D. Oro, João H. C. Wancura, Marcio A. Mazutti, Giovani L. Zabot, Marcus V. Tres
    World Journal of Microbiology and Biotechnology.2023;[Epub]     CrossRef
  • Fungal Biotransformation of Hazardous Organic Compounds in Wood Waste
    Magdalena Komorowicz, Dominika Janiszewska-Latterini, Anna Przybylska-Balcerek, Kinga Stuper-Szablewska
    Molecules.2023; 28(12): 4823.     CrossRef
  • Degradation effectiveness of hexachlorohexane (ϒ-HCH) by bacterial isolate Bacillus cereus SJPS-2, its gene annotation for bioremediation and comparison with Pseudomonas putida KT2440
    Shweta Jaiswal, Dileep Kumar Singh, Pratyoosh Shukla
    Environmental Pollution.2023; 318: 120867.     CrossRef
  • Biodegradation of Benzo[a]pyrene by a White-Rot Fungus Phlebia acerina: Surfactant-Enhanced Degradation and Possible Genes Involved
    Wenquan Zhang, Qiaoyu Li, Jianqiao Wang, Ziyu Wang, Hongjie Zhan, Xiaolong Yu, Yan Zheng, Tangfu Xiao, Li-Wei Zhou
    Journal of Fungi.2023; 9(10): 978.     CrossRef
  • Current status of pesticide effects on environment, human health and it’s eco-friendly management as bioremediation: A comprehensive review
    Vinay Mohan Pathak, Vijay K. Verma, Balwant Singh Rawat, Baljinder Kaur, Neelesh Babu, Akansha Sharma, Seeta Dewali, Monika Yadav, Reshma Kumari, Sevaram Singh, Asutosh Mohapatra, Varsha Pandey, Nitika Rana, Jose Maria Cunill
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Bibliometric analysis of global research on white rot fungi biotechnology for environmental application
    Pengfei Xiao, Dedong Wu, Jianqiao Wang
    Environmental Science and Pollution Research.2022; 29(1): 1491.     CrossRef
  • Microbial Degradation of Aldrin and Dieldrin: Mechanisms and Biochemical Pathways
    Shimei Pang, Ziqiu Lin, Jiayi Li, Yuming Zhang, Sandhya Mishra, Pankaj Bhatt, Shaohua Chen
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Myco-remediation of Chlorinated Pesticides: Insights Into Fungal Metabolic System
    Priyanka Bokade, Hemant J. Purohit, Abhay Bajaj
    Indian Journal of Microbiology.2021; 61(3): 237.     CrossRef
  • Microbial degradation of recalcitrant pesticides: a review
    Sanchali Bose, P. Senthil Kumar, Dai-Viet N. Vo, N. Rajamohan, R. Saravanan
    Environmental Chemistry Letters.2021; 19(4): 3209.     CrossRef
  • Biodegradation of atrazine and ligninolytic enzyme production by basidiomycete strains
    Caroline Henn, Diego Alves Monteiro, Mauricio Boscolo, Roberto da Silva, Eleni Gomes
    BMC Microbiology.2020;[Epub]     CrossRef
Anti-varicella-zoster virus activity of cephalotaxine esters in vitro
Jung-Eun Kim , Yoon-Jae Song
J. Microbiol. 2019;57(1):74-79.   Published online November 19, 2018
DOI: https://doi.org/10.1007/s12275-019-8514-z
  • 44 View
  • 0 Download
  • 30 Web of Science
  • 28 Crossref
AbstractAbstract
Harringtonine (HT) and homoharringtonine (HHT), alkaloid esters isolated from the genus Cephalotaxus, exhibit antitumor activity. A semisynthetic HHT has been approved for treatment of chronic myelogenous leukemia. In addition to antileukemic activity, HT and HHT are reported to possess potent antiviral activity. In this study, we investigated the effects of HT and HHT on replication of varicella-zoster virus (VZV) in vitro. HT and HHT, but not their biologically inactive parental alkaloid cephalotaxine (CET), significantly inhibited replication of recombinant VZV-pOka luciferase. Furthermore, HT and HHT, but not CET, strongly induced down-regulation of VZV lytic genes and exerted potent antiviral effects against a VZV clinical isolate. The collective data support the utility of HT and HHT as effective antiviral candidates for treatment of VZV-associated diseases.

Citations

Citations to this article as recorded by  
  • Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications
    Somanjana Khatua, Sudeshna Nandi, Anish Nag, Surjit Sen, Nilanjan Chakraborty, Arghya Naskar, Eda Sönmez Gürer, Daniela Calina, Krishnendu Acharya, Javad Sharifi-Rad
    European Journal of Medical Research.2024;[Epub]     CrossRef
  • The structure and bioactivities of Stemona alkaloids and alkaloids with [1,2-α] azepine nucleus (2009–2021)
    Yang Xu, Junming Liang, Yushu Yan, Dejuan Sun, Hua Li, Lixia Chen
    Phytochemistry Reviews.2024; 23(3): 657.     CrossRef
  • An Integrated Strategy for Establishing the Chemical Profile of Premna Microphylla Turcz. Leaves and Metabolites in Vivo
    Jinhong Cai, Shenghong Guan, Xueli Hu, Xuezhao Chen, Xiaosun Liu, Shouxin Li, Jingkui Tian, Ping Wang, Hua Gu, Xiaoyong Zhang
    Journal of AOAC International.2024;[Epub]     CrossRef
  • Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry
    Zhiwei Yang, Xinyue Fu, Yizhen Zhao, Xuhua Li, Jiangang Long, Lei Zhang
    International Journal of Biological Macromolecules.2023; 240: 124352.     CrossRef
  • The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
    Lukas Wettstein, Frank Kirchhoff, Jan Münch
    International Journal of Molecular Sciences.2022; 23(3): 1351.     CrossRef
  • Disease Markers and Therapeutic Targets for Rheumatoid Arthritis Identified by Integrating Bioinformatics Analysis with Virtual Screening of Traditional Chinese Medicine
    Jijia Sun, Baocheng Liu, Ying Yuan, Lei Zhang, Jianying Wang
    Frontiers in Bioscience-Landmark.2022;[Epub]     CrossRef
  • Harringtonine Ester Derivatives with Enhanced Antiproliferative Activities against HL-60 and HeLa Cells
    Akihiro Ochi, Makoto Yoritate, Tomofumi Miyamoto, Kazuteru Usui, Gorawit Yusakul, Waraporn Putalun, Hiroyuki Tanaka, Go Hirai, Satoshi Morimoto, Seiichi Sakamoto
    Journal of Natural Products.2022; 85(2): 345.     CrossRef
  • Clinical Management of Herpes Simplex Virus Keratitis
    Bisant A. Labib, DeGaulle I. Chigbu
    Diagnostics.2022; 12(10): 2368.     CrossRef
  • Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism
    Thanet Pitakbut, Gia-Nam Nguyen, Oliver Kayser
    Planta Medica.2022; 88(12): 1047.     CrossRef
  • Rapid classification and identification of chemical constituents in Epimedium koreanum Nakai by UPLC‐Q‐TOF‐MS combined with data post‐processing techniques
    Ning Li, Lijuan Xie, Na Yang, Guijiang Sun, Hui Liu, Chenghao Bi, Jingyi Duan, Yu Yuan, Hongxin Yu, Yanyan Xu, Yubo Li
    Phytochemical Analysis.2021; 32(4): 575.     CrossRef
  • Progress in structure, synthesis and biological activity of natural cephalotane diterpenoids
    Chunyu Jiang, Jingjing Xue, Yizhen Yuan, Yanzhi Li, Chunxue Zhao, Qinxue Jing, Xin Zhang, Mengyue Yang, Tong Han, Jiao Bai, Zhanlin Li, Dahong Li, Huiming Hua
    Phytochemistry.2021; 192: 112939.     CrossRef
  • Cephalotaxine-type alkaloids with antiproliferation effects from the branches and leaves of Cephalotaxus fortunei var. alpina
    Yan-Zhi Li, Yue-Tong Wang, Chun-Xue Zhao, Qin-Xue Jing, Chun-Yu Jiang, Bin Lin, Da-Hong Li, Bing-Qian Li, Yong-Kui Jing, Jiu-Zhi Yuan, Hui-Ming Hua
    Fitoterapia.2021; 155: 105037.     CrossRef
  • Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
    Rajeev K. Singla, Xuefei He, Hitesh Chopra, Christos Tsagkaris, Li Shen, Mohammad Amjad Kamal, Bairong Shen
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Medicinal plant-derived compounds as potential phytotherapy forCOVID-19: Future perspectives
    M. El-Darier Salama, A. Rashed Suzan, Fayez Ayat, S. Hassanein Sarah, R. Sharaby Muhammed, M. Tawfik Noran, Mansour Heba, Adel Mohamed
    Journal of Pharmacognosy and Phytotherapy.2021; 13(3): 68.     CrossRef
  • A Review on Synthesis, Reactions and Biological Properties of Seven Membered Heterocyclic Compounds: Azepine, Azepane, Azepinone
    Manvinder Kaur, Sonali Garg, Dharambeer S. Malhi, Harvinder S. Sohal
    Current Organic Chemistry.2021; 25(4): 449.     CrossRef
  • Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression
    Ye Liu, Qiao You, Fang Zhang, Deyan Chen, Zhenping Huang, Zhiwei Wu
    Frontiers in Microbiology.2021;[Epub]     CrossRef
  • Advances and Perspectives in the Management of Varicella-Zoster Virus Infections
    Graciela Andrei, Robert Snoeck
    Molecules.2021; 26(4): 1132.     CrossRef
  • Ethnopharmacology, chemodiversity, and bioactivity of Cephalotaxus medicinal plants
    Da-Cheng HAO, Xu-Dong HOU, Xiao-Jie GU, Pei-Gen XIAO, Guang-Bo GE
    Chinese Journal of Natural Medicines.2021; 19(5): 321.     CrossRef
  • Natural Products and Their Derivatives against Human Herpesvirus Infection
    Chattarin Ruchawapol, Man Yuan, Si-Min Wang, Wen-Wei Fu, Hong-Xi Xu
    Molecules.2021; 26(20): 6290.     CrossRef
  • Compilation of antiviral treatments and strategies to fight fish viruses
    Patricia Pereiro, Antonio Figueras, Beatriz Novoa
    Reviews in Aquaculture.2021; 13(3): 1223.     CrossRef
  • Small Molecule Drug Candidates for Managing the Clinical Symptoms of COVID-19: a Narrative Review
    Chawon Yun, Hyun Jae Lee, Choong Jae Lee
    Biomolecules & Therapeutics.2021; 29(6): 571.     CrossRef
  • Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms
    Zheng-Zong Lai, Yi-Jung Ho, Jeng-Wei Lu
    Molecules.2020; 25(18): 4082.     CrossRef
  • Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19
    Sherif T. S. Hassan
    Viruses.2020; 12(4): 476.     CrossRef
  • Alkaloids: Therapeutic Potential against Human Coronaviruses
    Burtram C. Fielding, Carlos da Silva Maia Bezerra Filho, Nasser S. M. Ismail, Damião Pergentino de Sousa
    Molecules.2020; 25(23): 5496.     CrossRef
  • Potential Antiviral Options against SARS-CoV-2 Infection
    Aleksandr Ianevski, Rouan Yao, Mona Høysæter Fenstad, Svetlana Biza, Eva Zusinaite, Tuuli Reisberg, Hilde Lysvand, Kirsti Løseth, Veslemøy Malm Landsem, Janne Fossum Malmring, Valentyn Oksenych, Sten Even Erlandsen, Per Arne Aas, Lars Hagen, Caroline H. P
    Viruses.2020; 12(6): 642.     CrossRef
  • Inhibitory effects of homoharringtonine on foot and mouth disease virus in vitro
    Mei‐jiao Gong, Shi‐fang Li, Yin‐li Xie, Fu‐rong Zhao, Jun‐jun Shao, Yong‐guang Zhang, Wen‐hui Wang, Hui‐yun Chang
    Journal of Medical Virology.2019; 91(9): 1595.     CrossRef
  • Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
    Petter I. Andersen, Klara Krpina, Aleksandr Ianevski, Nastassia Shtaida, Eunji Jo, Jaewon Yang, Sandra Koit, Tanel Tenson, Veijo Hukkanen, Marit W. Anthonsen, Magnar Bjoras, Magnus Evander, Marc P. Windisch, Eva Zusinaite, Denis E. Kainov
    Viruses.2019; 11(10): 964.     CrossRef
  • Cytostatic and Cytotoxic Natural Products against Cancer Cell Models
    Taotao Ling, Walter H. Lang, Julie Maier, Marizza Quintana Centurion, Fatima Rivas
    Molecules.2019; 24(10): 2012.     CrossRef
Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons
Yee Ching Ng , Ye Won Kim , Jeong-Su Lee , Sung Joon Lee , Moon Jung Song
J. Microbiol. 2018;56(9):683-689.   Published online August 23, 2018
DOI: https://doi.org/10.1007/s12275-018-8228-7
  • 45 View
  • 0 Download
  • 16 Crossref
AbstractAbstract
Human noroviruses are the causative agents of non-bacterial gastroenteritis worldwide. The rapid onset and resolution of disease symptoms suggest that innate immune responses are critical for controlling norovirus infection; however, no effective antivirals are yet available. The present study was conducted to examine the antiviral activities of Schizonepeta tenuifolia Briquet extract (STE) against noroviruses. Treatment of human norovirus replicon-bearing HG23 cells with STE at 5 and 10 mg/ml concentrations resulted in the reduction in the viral RNA levels by 77.2% and 85.9%, respectively. STE had no cytotoxic effects on HG23 cells. Treatment of RAW 264.7 cells infected with murine norovirus 1 (MNV-1), a surrogate virus of human noroviruses, with STE at 10 and 20 μg/ml concentrations resulted in the reduction of viral replication by 58.5% and 84.9%, respectively. STE treatment induced the expression of mRNAs for type I and type II interferons in HG23 cells and upregulated the transcription of interferon-β in infected RAW 264.7 cells via increased phosphorylation of interferon regulatory factor 3, a critical transcription regulator for type I interferon production. These
results
suggest that STE inhibits norovirus replication through the induction of antiviral interferon production during virus replication and may serve as a candidate antiviral substance for treatment against noroviruses.

Citations

Citations to this article as recorded by  
  • Comparison of Three Different Extraction Methods on Schizonepeta tenuifolia (Benth.) Briq Essential Oil: Chemical Constituents and in Vitro and in Silico Biological Activities
    Linhong He, Lijuan Zhang, Xi Bai
    Chemistry & Biodiversity.2024;[Epub]     CrossRef
  • Systems Pharmacological Approach to Identification of Schizonepeta teunifolia Extract via Active Ingredients Analysis and Cytotoxicity Effect on A549 Cell Lines
    Ga Ram Yang, Ji Eun Choo, Youn Sook Kim, Won Gun Ahn
    Korean Journal of Acupuncture.2024; 41(1): 7.     CrossRef
  • Chemical Characteristics and Comparison of Schizonepetae Herba and Schizonepetae Herba Carbonisata by Combination of GC–MS and UHPLC–MS Strategies
    Ding Xiaoying, Shenghui Hao, Hengyang Li, Tao Wang, Wenjie Li, Shengjiang Guan, Yuguang Zheng, Long Guo, Dan Zhang
    Journal of AOAC International.2023; 106(4): 970.     CrossRef
  • Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19
    Jaung-Geng Lin, Guan-Jhong Huang, Yi-Chang Su
    Journal of Biomedical Science.2023;[Epub]     CrossRef
  • Colorimetric Parameters Correlated with the Variation in the Marker Constituent Contents During the Stir-fry Processing of Schizonepetae Spica
    Xindan Liu, Ying Zhang, Menghua Wu, Zhiguo Ma, Hui Cao
    Food Analytical Methods.2022; 15(5): 1300.     CrossRef
  • Discrimination and Characterization of the Volatile Organic Compounds in Schizonepetae Spica from Six Regions of China Using HS-GC-IMS and HS-SPME-GC-MS
    Chao Li, Huiying Wan, Xinlong Wu, Jiaxin Yin, Limin Zhu, Hanjiang Chen, Xinbo Song, Lifeng Han, Wenzhi Yang, Heshui Yu, Zheng Li
    Molecules.2022; 27(14): 4393.     CrossRef
  • Review on Chemical Constituents of Schizonepeta tenuifolia Briq. and Their Pharmacological Effects
    Xueying Zhao, Mingwei Zhou
    Molecules.2022; 27(16): 5249.     CrossRef
  • A Comprehensive Strategy Based on UPLC-Q/TOF-MS for the Identification of Compounds in a Chinese Patent Medicine, Xiao’er Chiqiao Qingre Granules
    Gang Tian, Mengting Gao, Chao Li, Fei Shen, Feng Zhu, Xin Li, Yifei Wang, Beihua Bao, Li Zhang, Zongli Huo, Weifeng Yao
    Journal of Chromatographic Science.2022; 61(1): 38.     CrossRef
  • A review of the botany, traditional uses, phytochemistry and pharmacology of Nepeta tenuifolia Briq.
    Mingqiu Shan, Yulan Jiang, Yuanyuan Fu, Yongyi Zhou, Zhihui Lu, Sheng Yu, Hui Yan, Chanchan Liu, Peidong Chen, Beihua Bao, Li Zhang, Qinan Wu
    Phytochemistry Reviews.2021; 20(5): 991.     CrossRef
  • β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
    Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, Seenipandi Arunachalam, MF Nagoor Meeran, Hayate Javed, Chandragouda R. Patil, Sameer N. Goyal, Shreesh Ojha
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Spectrum–effect relationship between GC‐QTOF‐MS fingerprint and antioxidant, anti‐inflammatory activities of Schizonepeta tenuifolia essential oil
    Xi Bai, Liu Liu, Junping Zhang, Li Chen, Tao Wu, Haji Akber Aisa, Maitinuer Maiwulanjiang
    Biomedical Chromatography.2021;[Epub]     CrossRef
  • Interferon responses to norovirus infections: current and future perspectives
    Aminu S. Jahun, Ian G. Goodfellow
    Journal of General Virology .2021;[Epub]     CrossRef
  • Comparisons of the anti-inflammatory, antiviral, and hemostatic activities and chemical profiles of raw and charred Schizonepetae Spica
    Xindan Liu, Zihan Huang, Jinju Zhang, Yu Zhou, Ying Zhang, Menghua Wu, Zhiguo Ma, Hui Cao
    Journal of Ethnopharmacology.2021; 278: 114275.     CrossRef
  • The Potential Transformation Mechanisms of the Marker Components of Schizonepetae Spica and Its Charred Product
    Xindan Liu, Ying Zhang, Menghua Wu, Zhiguo Ma, Hui Cao
    Molecules.2020; 25(16): 3749.     CrossRef
  • Color discrimination and gas chromatography-mass spectrometry fingerprint based on chemometrics analysis for the quality evaluation of Schizonepetae Spica
    Xindan Liu, Ying Zhang, Menghua Wu, Zhiguo Ma, Hui Cao, Joseph Banoub
    PLOS ONE.2020; 15(1): e0227235.     CrossRef
  • Glycolysis Is an Intrinsic Factor for Optimal Replication of a Norovirus
    Karla D. Passalacqua, Jia Lu, Ian Goodfellow, Abimbola O. Kolawole, Jacob R. Arche, Robert J. Maddox, Kelly E. Carnahan, Mary X. D. O’Riordan, Christiane E. Wobus, Mary K. Estes
    mBio.2019;[Epub]     CrossRef
Antiviral activity of Poncirus trifoliata seed extract against oseltamivirresistant influenza virus
Yoonki Heo , Yeondong Cho , Kwon sung Ju , Hansam Cho , Ki Hoon Park , Hanul Choi , Jong Kwang Yoon , Chiung Moon , Young Bong Kim
J. Microbiol. 2018;56(8):586-592.   Published online July 25, 2018
DOI: https://doi.org/10.1007/s12275-018-8222-0
  • 47 View
  • 0 Download
  • 15 Crossref
AbstractAbstract
The emergence of oseltamivir-resistant variants of influenza virus has highlighted the necessity for the development of more effective novel antiviral drugs. To date, numerous researchers have focused on developing antiviral drugs using natural resources, such as traditional herbal medicines. Poncirus trifoliata is widely used in oriental medicine as a remedy for gastritis, dysentery, inflammation and digestive ulcers. In this study, we investigated the potential antiviral effect of the Poncirus trifoliata orange seed extract against influenza virus. An ethanol extract of Poncirus trifoliata seeds (PTex) inhibited the activity of influenza viruses, in particular, oseltamivir- resistant strains, in Madin-Darby canine kidney cells. In contrast to oseltamivir, PTex exerted a significant inhibitory effect on the cellular penetration pathway of the virus rather than HA receptor binding. The potent antiviral effect and novel working mechanism of PTex support its further development as an effective natural antiviral drug with a wide spectrum of activity against influenza and oseltamivir-resistant viruses.

Citations

Citations to this article as recorded by  
  • A Comprehensive Study on Natural Products and their Bioactive Constituents to Cure Respiratory Diseases
    Avadh Biharee, Lokesh Chaudhari, Sudha Bhartiya, Shivam Kumar Kori, Anu Chaudhary, Dheeraj Dubey, Arpita Yadav
    The Natural Products Journal.2024;[Epub]     CrossRef
  • Seed extracts as an effective strategy in the control of plant pathogens: Scalable industry bioactive compounds for sustainable agriculture
    Tamara Sánchez-Gómez, Óscar Santamaría, Jorge Martín-García, Jorge Poveda
    Biocatalysis and Agricultural Biotechnology.2024; 60: 103332.     CrossRef
  • Insights into identifying resistance genes for cold and disease stresses through chromosome-level reference genome analyses of Poncirus polyandra
    Shanshan Zhang, Jian Chen, Chuanguang Zhang, Siqi Zhang, Xiaolei Zhang, Lanjing Gao, Wenzhong Yang
    Genomics.2023; 115(3): 110617.     CrossRef
  • Poncirus trifoliata (L.) Raf. Seed Extract Induces Cell Cycle Arrest and Apoptosis in the Androgen Receptor Positive LNCaP Prostate Cancer Cells
    Francesca Giordano, Stefano Comità, Giulia Venneri, Vittoria Rago, Giuseppina Daniela Naimo, Francesca De Amicis, Anna De Bartolo, Rosa Tundis, Loredana Mauro, Maria Luisa Panno
    International Journal of Molecular Sciences.2023; 24(22): 16351.     CrossRef
  • Structural Bioinformatics Used to Predict the Protein Targets of Remdesivir and Flavones in SARS-CoV-2 Infection
    Avram Speranta, Laura Manoliu, Catalina Sogor, Maria Mernea, Corina Duda Seiman, Daniel Duda Seiman, Carmen Chifiriuc
    Medicinal Chemistry.2022; 18(3): 382.     CrossRef
  • Bioactive Chemical Constituents and Pharmacological Activities of Ponciri Fructus
    Gopal Lamichhane, Jitendra Pandey, Hari Prasad Devkota
    Molecules.2022; 28(1): 255.     CrossRef
  • Plant-Based Natural Products and Extracts: Potential Source to Develop New Antiviral Drug Candidates
    Eyana Thomas, Laura E. Stewart, Brien A. Darley, Ashley M. Pham, Isabella Esteban, Siva S. Panda
    Molecules.2021; 26(20): 6197.     CrossRef
  • COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds
    Oksana Sytar, Marian Brestic, Shokoofeh Hajihashemi, Milan Skalicky, Jan Kubeš, Laura Lamilla-Tamayo, Ulkar Ibrahimova, Sayyara Ibadullayeva, Marco Landi
    Molecules.2021; 26(3): 727.     CrossRef
  • KIF11 inhibition decreases cytopathogenesis and replication of influenza A virus
    Dong-In Kim, Ji-Hun Kang, Eui-Ho Kim, Young-Jin Seo
    Molecular & Cellular Toxicology.2021; 17(2): 201.     CrossRef
  • Chios mastic gum inhibits influenza A virus replication and viral pathogenicity
    Dong-In Kim, Yong-Bin Cho, Younghyun Lim, So-Hee Hong, Bumsuk Hahm, Sang-Myeong Lee, Se Chan Kang, Young-Jin Seo
    Journal of General Virology .2021;[Epub]     CrossRef
  • Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection
    Fang-Ju Cheng, Thanh-Kieu Huynh, Chia-Shin Yang, Dai-Wei Hu, Yi-Cheng Shen, Chih-Yen Tu, Yang-Chang Wu, Chih-Hsin Tang, Wei-Chien Huang, Yeh Chen, Chien-Yi Ho
    Nutrients.2021; 13(8): 2800.     CrossRef
  • Selective and ATP‐competitive kinesin KIF18A inhibitor suppresses the replication of influenza A virus
    Yong‐Bin Cho, Sungguan Hong, Kyung‐Won Kang, Ji‐Hun Kang, Sang‐Myeong Lee, Young‐Jin Seo
    Journal of Cellular and Molecular Medicine.2020; 24(10): 5463.     CrossRef
  • Natural products against acute respiratory infections: Strategies and lessons learned
    Julia Langeder, Ulrike Grienke, Ya Chen, Johannes Kirchmair, Michaela Schmidtke, Judith M. Rollinger
    Journal of Ethnopharmacology.2020; 248: 112298.     CrossRef
  • Retracted: Phytotherapeutic options for the treatment of COVID‐19: A concise viewpoint
    Misbahud Din, Fawad Ali, Abdul Waris, Fatima Zia, Muhammad Ali
    Phytotherapy Research.2020; 34(10): 2431.     CrossRef
  • Chung Hun Wha Dam Tang attenuates atherosclerosis in apolipoprotein E-deficient mice via the NF-κB pathway
    Yeonsoo Joe, Md Jamal Uddin, Jeongmin Park, Jinhyun Ryu, Gyeong Jae Cho, Jeong Woo Park, Hye-Seon Choi, Min Ho Cha, Stefan W. Ryter, Hun Taeg Chung
    Biomedicine & Pharmacotherapy.2019; 120: 109524.     CrossRef
An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication
Seong Eun Jin , Jung-Eun Kim , Sun Yeou Kim , Bang Ju Park , Yoon-Jae Song
J. Microbiol. 2017;55(12):984-988.   Published online December 7, 2017
DOI: https://doi.org/10.1007/s12275-017-7477-1
  • 47 View
  • 0 Download
  • 7 Crossref
AbstractAbstract
Hepatitis E virus (HEV) is an etiological agent of acute hepatitis E, a self-limiting disease prevalent in developing countries. HEV can cause fulminant hepatic failure with high mortality rates in pregnant women, and genotype 3 is reported to trigger chronic hepatitis in immunocompromised individuals worldwide. Screening of plant extracts for compounds with potential anti-HEV effects led to the identification of a 70% ethanol extract of Lysimachia mauritiana (LME) that interferes with replication of the swine HEV genotype 3 replicon. Furthermore, LME significantly inhibited replication of HEV genotype 3 and expression of HEV ORF2 in infected cells without exerting cytotoxic effects. Collectively, our findings demonstrate the potential utility of LME in the development of novel antiviral drugs against HEV infection.

Citations

Citations to this article as recorded by  
  • Host-targeting antivirals for chronic viral infections of the liver
    Nicola Frericks, Mara Klöhn, Frauke Lange, Lilli Pottkämper, Arnaud Carpentier, Eike Steinmann
    Antiviral Research.2025; 234: 106062.     CrossRef
  • Seedling Growth of Lysimachia mauritiana Lam. by Cell Size and Nutrient Solution Concentration
    Eun Ji Choi, Jun Young Kim, Gyeong Ho Jang, Soo Hoon Kim, Sang Im Oh, Hong Min Koh, SiU Hong, Mijeong Yoon, Chung Ho Ko
    Flower Research Journal.2024; 32(2): 103.     CrossRef
  • Lysimachia mauritiana Lam. Extract Alleviates Airway Inflammation Induced by Particulate Matter Plus Diesel Exhaust Particles in Mice
    Yoon-Young Sung, Seung-Hyung Kim, Won-Kyung Yang, Heung Joo Yuk, Mi-Sun Kim, Dong-Seon Kim
    Nutrients.2024; 16(21): 3732.     CrossRef
  • Hotspots and trends in global antiviral herbal basic research: A visualization analysis
    Liangyu Hu, Chunying Wang, Yang Zhang
    European Journal of Integrative Medicine.2024; 72: 102419.     CrossRef
  • HPLC Analysis of Polyphenolic Compounds in Lysimachia nummularia L. and Comparative Determination of Antioxidant Capacity
    Felicia Suciu, Iuliana Stoicescu, Elena Lupu, Adina Musuc, Antoanela Popescu, Magdalena Mititelu, Adrian Roșca, Denisa-Elena Dumitrescu, Florin Badea, Aureliana Caraiane, Victoria Badea
    Applied Sciences.2023; 13(4): 2159.     CrossRef
  • Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health
    Srinivas Reddy Pallerla, Dominik Harms, Reimar Johne, Daniel Todt, Eike Steinmann, Mathias Schemmerer, Jürgen J. Wenzel, Jörg Hofmann, James Wai Kuo Shih, Heiner Wedemeyer, C.-Thomas Bock, Thirumalaisamy P. Velavan
    Pathogens.2020; 9(10): 856.     CrossRef
  • Hepatitis E Virus Drug Development
    Volker Kinast, Thomas L Burkard, Daniel Todt, Eike Steinmann
    Viruses.2019; 11(6): 485.     CrossRef
Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate
Jin Soo Shin , Keun Bon Ku , Yejin Jang , Yi-Seul Yoon , Daeho Shin , Oh Seung Kwon , Yun Young Go , Seong Soon Kim , Myoung Ae Bae , Meehyein Kim
J. Microbiol. 2017;55(12):979-983.   Published online December 7, 2017
DOI: https://doi.org/10.1007/s12275-017-7371-x
  • 53 View
  • 0 Download
  • 10 Crossref
AbstractAbstract
Influenza viruses are major human respiratory pathogens that cause high morbidity and mortality worldwide. Currently, prophylactic vaccines and therapeutic antiviral agents are used to prevent and control influenza virus infection. Oseltamivir free base (OSV-FB), a modified generic antiviral drug of Tamiflu (oseltamivir phosphate, OSV-P), was launched in the Republic of Korea last year. Here, we examine the bioequivalence of these two compounds by assessing their antiviral efficacy in infected cells and in a mouse model. It was observed that both antivirals showed comparable efficacy against 11 different influenza A and B viruses in vitro. Moreover, in mice infected with influenza A virus (mouse-adapted A/Puerto Rico/8/34), they showed a dose-dependent therapeutic activity and alleviated infection-mediated reductions in body weight, leading to significantly better survival. There was histopathological disappearance of virus-induced inflammatory cell infiltration of the lung after oral treatment with either antiviral agent (at 10 mg/kg). Pharmacokinetic analysis also exhibited similar plasma concentrations of the active drug, oseltamivir carboxylate, metabolised from both OSVB and OSV-P. This is the first report showing bioequivalence of OSV-FB to its phosphate salt form in the mouse system. The free base drug has some beneficial points including simple drug formulation process and reduced risk of undesirable cation-phosphate precipitation within solution. The long term stability of OSV-FB requires further monitoring when it is provided as a national stock in readiness for an influenza pandemic.

Citations

Citations to this article as recorded by  
  • Interaction mechanism of oseltamivir phosphate with bovine serum albumin: multispectroscopic and molecular docking study
    Jing Yu, Jian-Ming Liu, Hui-Yi Chen, Wei-Ming Xiong
    BMC Chemistry.2024;[Epub]     CrossRef
  • A Lysosome-Targeting hNEU1 Inhibitor Treats Myocardial Infarction: A Potential Therapeutic Breakthrough
    Wen Zhou, Wanxiang Yang, Ping Jiang, Shaohua Gou
    Journal of Medicinal Chemistry.2024; 67(18): 16899.     CrossRef
  • The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs
    Ghassan Mudher Hashim , Ghaidaa S. Hameed , Dalya Basil Hanna
    Al Mustansiriyah Journal of Pharmaceutical Sciences.2023; 23(3): 231.     CrossRef
  • Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics
    Ran Chen, Tingting Wang, Jie Song, Daojun Pu, Dan He, Jianjun Li, Jie Yang, Kailing Li, Cailing Zhong, Jingqing Zhang
    International Journal of Nanomedicine.2021; Volume 16: 4959.     CrossRef
  • Multistage Extraction of Star Anise and Black Pepper Derivatives for Antibacterial, Antioxidant, and Anticancer Activity
    Helin Li, Xiaoyu Wu, Xin Li, Xiaobing Cao, Yanjun Li, Huaru Cao, Yongzhi Men
    Frontiers in Chemistry.2021;[Epub]     CrossRef
  • Development of Sustained Release Oseltamivir Phosphate Dry Powder Inhaler: In-Vitro Characterization and In-Vivo Toxicological Studies
    Harshal Sahastrabudhe, Prathmesh Kenjale, Varsha Pokharkar
    Current Drug Delivery.2020; 17(8): 703.     CrossRef
  • In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus
    Yejin Jang, Jin Soo Shin, Joo-Youn Lee, Heegwon Shin, Sang Jick Kim, Meehyein Kim
    Viruses.2020; 12(5): 581.     CrossRef
  • A new naphthoquinone analogue and antiviral constituents from the root of Rhinacanthus nasutus
    Tran Minh Ngoc, Nguyen Thi Thanh Phuong, Nguyen Minh Khoi, SeonJu Park, Hee Jae Kwak, Nguyen Xuan Nhiem, Bui Thi Thu Trang, Bui Huu Tai, Jae-Hyoung Song, Hyun-Jeong Ko, Seung Hyun Kim
    Natural Product Research.2019; 33(3): 360.     CrossRef
  • Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function
    Yejin Jang, Jin Soo Shin, Yi-Seul Yoon, Yun Young Go, Hye Won Lee, Oh Seung Kwon, Sehee Park, Man-Seong Park, Meehyein Kim, Jae U. Jung
    Journal of Virology.2018;[Epub]     CrossRef
  • The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin
    Anna Luganini, Maria E. Terlizzi, Gianluca Catucci, Gianfranco Gilardi, Massimo E. Maffei, Giorgio Gribaudo
    Frontiers in Microbiology.2018;[Epub]     CrossRef
Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo
Prasanna Weeratunga , Thilina U. B. Herath , Tae-Hwan Kim , Hyun-Cheol Lee , Jae-Hoon Kim , Byeong-Hoon Lee , Eun-Seo Lee , Kiramage Chathuranga , W. A. Gayan Chathuranga , Chul-Su Yang , Jin Yeul Ma , Jong-Soo Lee
J. Microbiol. 2017;55(11):909-917.   Published online October 27, 2017
DOI: https://doi.org/10.1007/s12275-017-7392-5
  • 49 View
  • 0 Download
  • 15 Crossref
AbstractAbstract
Dense granule protein-7 (GRA-7) is an excretory protein of Toxoplasma gondii. It is a potential serodiagnostic marker and vaccine candidate for toxoplasmosis. Previous reports demonstrated that GRA-7 induces innate immune responses in macrophages by interacting with TRAF6 via the MyD88- dependent pathway. In the present study, we evaluated the antiviral activity and induction of an antiviral state by GRA-7 both in vitro and in vivo. It was observed that GRA-7 markedly reduced the replication of vesicular stomatitis virus (VSVGFP), influenza A virus (PR8-GFP), coxsackievirus (H3- GFP), herpes simplex virus (HSV-GFP), and adenovirus-GFP in epithelial (HEK293T/HeLa) and immune (RAW264.7) cells. These antiviral activities of GRA-7 were attributed to the induction of type I interferon (IFN) signaling, resulting in the secretion of IFNs and pro-inflammatory cytokines. Additionally, in BALB/c mice, intranasal administration of GRA-7 prevented lethal infection by influenza A virus (H1N1) and exhibited prophylactic effects against respiratory syncytial virus (RSV-GFP). Collectively, these results suggested that GRA-7 exhibits immunostimulatory and broad spectrum antiviral activities via type I IFN signaling. Thus, GRA-7 can be potentially used as a vaccine adjuvant or as a candidate drug with prophylactic potential against viruses.

Citations

Citations to this article as recorded by  
  • Effect of SARS-CoV-2 and Toxoplasma gondii co-infection on IFN-γ and TNF-α expression and its impact on disease severity
    Magda S.A. Abdeltawab, Mohamed Fateen, Shimaa Saad El-Din, Riem M. Elmessiery, Osama Mohammady Mohamed, Khaled Marzouk Sadek, Engy Medhat, Alshaimaa M.R. Hamed
    Cytokine.2024; 177: 156545.     CrossRef
  • Impact of latent toxoplasmosis on pneumonic and non-pneumonic COVID-19 patients with estimation of relevant oxidative stress biomarkers
    Doaa A. Hamdy, Ragaey A. Eid, Heba Abdel-Tawab, Mohamed A. El-Badry, Abdelrahman M. Abdallah, Wegdan M. Abd El Wahab
    Folia Parasitologica.2024;[Epub]     CrossRef
  • IFNs in host defence and parasite immune evasion during Toxoplasma gondii infections
    Carsten G. K. Lüder
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Current vaccine candidate of toxoplasmosis
    Eden WOLDEGERIMA, Fasika GETACHEW, Meseret MISGANAW, Yohannes MESFIN, Debaka BELETE, Tekeba SISAY, Nega BERHANE
    Journal of Life Science and Biomedicine.2024; : 54.     CrossRef
  • Prevalence of Toxoplasma gondii infection in COVID-19 patients: A systematic review and meta-analysis
    Mahdi Fakhar, Khadijeh Najafi Ghobadi, Nastaran Barati, Salman Zafari, Seyed Ali Hosseini, Eissa Soleymani, Seyedmousa Motavallihaghi
    Microbial Pathogenesis.2024; 197: 107064.     CrossRef
  • Clinical and Immunological Impacts of Latent Toxoplasmosis on COVID-19 Patients
    Samar Habib, Eman Hamza, Randa El-Gamal, Nessma A Nosser, Wafaa A Aboukamar, Sherehan Abdelsalam, Ali Sobh, Mohamed Elegezy, Mohamed Elbayoumy, Waleed Eldars, Khaled Elmasry, Marwa H Elnagdy
    Cureus.2023;[Epub]     CrossRef
  • Association between breakthrough infection with COVID-19 and Toxoplasma gondii: a cross-sectional study
    Marwa A. Gouda, Hind S. AboShabaan, Ahmed S. Abdelgawad, Aliaa Sabry Abdel Wahed, Khaled A. Abd El-Razik, Yara Elsaadawy, Ayman. A. Abdel-Wahab, Yousry Hawash
    Scientific Reports.2023;[Epub]     CrossRef
  • Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran
    Ali Geraili, Alireza Badirzadeh, Maryam Sadeghi, Seyed Mahmoud Mousavi, Parisa Mousavi, Zabihollah Shahmoradi, Sayed-Mohsen Hosseini, Seyed Hossein Hejazi, Raheleh Rafiei-Sefiddashti
    Journal of Parasitic Diseases.2023; 47(1): 185.     CrossRef
  • Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection
    Nadia Arcon, Mariano S. Picchio, Ignacio M. Fenoy, Rosalía E. Moretta, Ariadna S. Soto, Matías D. Perrone Sibilia, Vanesa R. Sánchez, Cecilia A. Prato, María Virginia Tribulatti, Alejandra Goldman, Valentina Martin
    Vaccine.2021; 39(6): 933.     CrossRef
  • GRA8 DNA vaccine formulations protect against chronic toxoplasmosis
    Muhammet Karakavuk, Hüseyin Can, Aytül Gül, Aysu Değirmenci Döşkaya, Sedef Erkunt Alak, Cemal Ün, Adnan Yüksel Gürüz, Mert Döşkaya
    Microbial Pathogenesis.2021; 158: 105016.     CrossRef
  • Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections
    Enas Fakhry Abdel-Hamed, Mohamed N. Ibrahim, Nahed E. Mostafa, Howayda S. F. Moawad, Nahla E. Elgammal, Ehab M. Darwiesh, Dina S. El-rafey, Nissreen E. ElBadawy, Emad Ali Al-Khoufi, Salwa I. Hindawi
    Gut Pathogens.2021;[Epub]     CrossRef
  • The role of polyspecific T-cell exhaustion in severe outcomes for COVID-19 patients having latent pathogen infections such as Toxoplasma gondii
    Kevin Roe
    Microbial Pathogenesis.2021; 161: 105299.     CrossRef
  • Preparation of colloidal gold immunochromatographic test strips for the diagnosis ofToxoplasma gondii
    Yuanxi Shen, Zhaozhe Wang, Jiajing Li, Rui Xu, Rongyi Ji, Jiaojiao Lin, Chuangang Zhu
    Food and Agricultural Immunology.2020; 31(1): 630.     CrossRef
  • A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations
    Łukasz Jankowiak, Lajos Rozsa, Piotr Tryjanowski, Anders Pape Møller
    Scientific Reports.2020;[Epub]     CrossRef
  • Characterization of a novel secretory spherical body protein in Babesia orientalis and Babesia orientalis-infected erythrocytes
    Jiaying Guo, Muxiao Li, Yali Sun, Long Yu, Pei He, Zheng Nie, Xueyan Zhan, Yangnan Zhao, Xiaoying Luo, Sen Wang, Siqi Aoyang, Qin Liu, Cuiqin Huang, Lan He, Junlong Zhao
    Parasites & Vectors.2018;[Epub]     CrossRef
Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state
Byeong-Hoon Lee , Kiramage Chathuranga , Md Bashir Uddin , Prasanna Weeratunga , Myun Soo Kim , Won-Kyung Cho , Hong Ik Kim , Jin Yeul Ma , Jong-Soo Lee
J. Microbiol. 2017;55(6):488-498.   Published online May 28, 2017
DOI: https://doi.org/10.1007/s12275-017-7088-x
  • 52 View
  • 0 Download
  • 21 Crossref
AbstractAbstract
Coptidis Rhizoma is derived from the dried rhizome of Ranun-culaceous plants and is a commonly used traditional Chinese medicine. Although Coptidis Rhizoma is commonly used for its many therapeutic effects, antiviral activity against respi-ratory syncytial virus (RSV) has not been reported in detail. In this study, we evaluated the antiviral activities of Coptidis Rhizoma extract (CRE) against RSV in human respiratory tract cell line (HEp2) and BALB/c mice. An effective dose of CRE significantly reduces the replication of RSV in HEp2 cells and reduces the RSV-induced cell death. This antiviral activity against RSV was through the induction of type I inter-feron-related signaling and the antiviral state in HEp2 cells. More importantly, oral administration of CRE exhibited prophylactic effects in BALB/c mice against RSV. In HPLC analysis, we found the presence of several compounds in the aqueous fraction and among them; we confirmed that pal-matine was related to the antiviral properties and immune- modulation effect. Taken together, an extract of Coptidis Rhi-zoma and its components play roles as immunomodulators and could be a potential source as promising natural antivirals that can confer protection to RSV. These outcomes should encourage further allied studies in other natural products.

Citations

Citations to this article as recorded by  
  • Antiviral effect of palmatine against infectious bronchitis virus through regulation of NF-κB/IRF7/JAK-STAT signalling pathway and apoptosis
    W. Zhang, Y. Chen, F. Yang, H. Zhang, T. Su, J. Wang, Y. Zhang, X. Song
    British Poultry Science.2024; 65(2): 119.     CrossRef
  • In Vitro Inhibitory Effect of Berberine Against Rotavirus
    Hue Thi Nguyen, Thi Nguyen Hoa‐Tran, Huy Quang Tran, Thuy Thi Thu Nguyen
    Chemistry & Biodiversity.2024;[Epub]     CrossRef
  • Network Pharmacology and Experimental Validation of Qingwen Baidu Decoction Therapeutic Potential in COVID-19-related Lung Injury
    Ju Yang, Zhao Zhang, Honghong Liu, Jiawei Wang, Shuying Xie, Pengyan Li, Jianxia Wen, Shizhang Wei, Ruisheng Li, Xiao Ma, Yanling Zhao
    Combinatorial Chemistry & High Throughput Screening.2024; 27(9): 1286.     CrossRef
  • Effect of miR-17 on Polygonum Cillinerve polysaccharide against transmissible gastroenteritis virus
    Xueqin Duan, Mengxin Xu, Yunying Wang, Nishang Liu, Xingchen Wang, Yingqiu Liu, Weimin Zhang, Wuren Ma, Lin Ma, Yunpeng Fan
    Frontiers in Veterinary Science.2024;[Epub]     CrossRef
  • The novel immunobiotic Clostridium butyricum S-45-5 displays broad-spectrum antiviral activity in vitro and in vivo by inducing immune modulation
    Kiramage Chathuranga, Yeseul Shin, Md Bashir Uddin, Jayoung Paek, W. A. Gayan Chathuranga, Yebin Seong, Lu Bai, Hongik Kim, Jeong Hwan Shin, Young-Hyo Chang, Jong-Soo Lee
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Interventional effect of processing temperature on anti-angiogenesis of Coptis chinensis and screening of active components by UPLC-MS/MS on quail chick chorioallantoic membrane model
    Dan Wang, Miao Qi, Hedi Zhao, Haozhong Wu, Han Chen, Yanan Lan, Yanmin Wang, Yani Jiang, Jingjuan Wang
    Journal of Ethnopharmacology.2023; 305: 116014.     CrossRef
  • Coptisine Inhibits Influenza Virus Replication by Upregulating p21
    Ming-Feng He, Jian-Hui Liang, Yan-Ni Shen, Chao-Wei Zhang, Kuang-Yang Yang, Li-Chu Liu, Qian Xie, Chun Hu, Xun Song, Yan Wang
    Molecules.2023; 28(14): 5398.     CrossRef
  • Synthesis of berberine derivatives and their antiviral activity toward respiratory syncytial virus
    Anna A. Shtro, Elizaveta D. Gladkova, Anastasia V. Galochkina, Yulia V. Nikolaeva, Angelika V. Garshinina, Darya N. Razgulyaeva, Evgeniy V. Sorokin, Tatyana R. Tsareva, Olga A. Luzina, Nariman F. Salakhutdinov
    Medicinal Chemistry Research.2023; 32(11): 2325.     CrossRef
  • A Global Perspective on Medicinal Plants and Phytochemicals with Antiviral Potentials in the Respiratory System
    Neda Mohamadi, Fariba Sharififar, Maryam Rameshk, Shahram Kalantari Khandani
    Anti-Infective Agents.2023;[Epub]     CrossRef
  • Refractory Chest Pain in Mild to Moderate Coronavirus Disease 2019 Successfully Treated with Saikanto, a Japanese Traditional Medicine
    Ryutaro Arita, Rie Ono, Natsumi Saito, Satoko Suzuki, Akiko Kikuchi, Minoru Ohsawa, Yasunori Tadano, Tetsuya Akaishi, Takeshi Kanno, Michiaki Abe, Ko Onodera, Shin Takayama, Tadashi Ishii
    The Tohoku Journal of Experimental Medicine.2022; 257(3): 241.     CrossRef
  • Pine Needle Extract Applicable to Topical Treatment for the Prevention of Human Papillomavirus Infection
    Hee-Jung Lee, Mina Park, HeeJae Choi, Aleksandra Nowakowska, Chiung Moon, Jong Hwan Kwak, Young Bong Kim
    Journal of Microbiology and Biotechnology.2021; 31(1): 137.     CrossRef
  • In Silico Target Analysis of Treatment for COVID-19 Using Huang-Lian-Shang-Qing-Wan, a Traditional Chinese Medicine Formula
    Ching-Wen Huang, Hai-Anh Ha, Shih-Chang Tsai, Chi-Cheng Lu, Chao-Ying Lee, Yuh-Feng Tsai, Fuu-Jen Tsai, Yu-Jen Chiu, Guo-Kai Wang, Chung-Hua Hsu, Jai-Sing Yang
    Natural Product Communications.2021;[Epub]     CrossRef
  • Exploring the Potential Targets and Mechanisms of Huang Lian Jie Du Decoction in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology
    Wang Liu, Yu Zeng, Yanda Li, Nanhong Li, Min Peng, Junfen Cheng, Binbin Tian, Mingdi Chen
    International Journal of General Medicine.2021; Volume 14: 9873.     CrossRef
  • Inhibitory Effect of Sargassum fusiforme and Its Components on Replication of Respiratory Syncytial Virus In Vitro and In Vivo
    Kiramage Chathuranga, Asela Weerawardhana, Niranjan Dodantenna, Lakmal Ranathunga, Won-Kyung Cho, Jin Yeul Ma, Jong-Soo Lee
    Viruses.2021; 13(4): 548.     CrossRef
  • Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish
    Acharya Balkrishna, Lakshmipathi Khandrika, Anurag Varshney
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Systematic screening and characterization of absorbed constituents and in vivo metabolites in rats after oral administration of Rhizoma coptidis using UPLC‐Q‐TOF/MS
    Xinchi Feng, Kun Wang, Xintong Hu, Liwei Chai, Shijie Cao, Liqin Ding, Feng Qiu
    Biomedical Chromatography.2020;[Epub]     CrossRef
  • Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation
    Acharya Balkrishna, Siva Kumar Solleti, Sudeep Verma, Anurag Varshney
    Molecules.2020; 25(21): 5091.     CrossRef
  • Palmatine: A review of pharmacological properties and pharmacokinetics
    Dominik Tarabasz, Wirginia Kukula‐Koch
    Phytotherapy Research.2020; 34(1): 33.     CrossRef
  • Anti-Respiratory Syncytial Virus Activity of Plantago asiatica and Clerodendrum trichotomum Extracts In Vitro and In Vivo
    Kiramage Chathuranga, Myun Soo Kim, Hyun-Cheol Lee, Tae-Hwan Kim, Jae-Hoon Kim, W. A. Gayan Chathuranga, Pathum Ekanayaka, H. M. S. M. Wijerathne, Won-Kyung Cho, Hong Ik Kim, Jin Yeul Ma, Jong-Soo Lee
    Viruses.2019; 11(7): 604.     CrossRef
  • Methanolic Extract of Rhizoma Coptidis Inhibits the Early Viral Entry Steps of Hepatitis C Virus Infection
    Ting-Chun Hung, Alagie Jassey, Chien-Ju Lin, Ching-Hsuan Liu, Chun-Ching Lin, Ming-Hong Yen, Liang-Tzung Lin
    Viruses.2018; 10(12): 669.     CrossRef
  • Metabolism of Rhizoma coptidis in Human Urine by Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry
    Qingshan Zhang, Gaowa Wang, Xi Chen, Zhiqiang Han, Xiangmei Chen, Risu Na, Haburi Jin, Ping Li, Renbatu Bu
    European Journal of Drug Metabolism and Pharmacokinetics.2018; 43(4): 441.     CrossRef
Review
REVIEW] Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies
Brian B. Gowen , Brady T. Hickerson
J. Microbiol. 2017;55(3):183-195.   Published online February 28, 2017
DOI: https://doi.org/10.1007/s12275-017-7029-8
  • 48 View
  • 0 Download
  • 12 Crossref
AbstractAbstract
A growing number of bunyaviruses are known to cause viral hemorrhagic fever (VHF), a severe febrile illness which can progress to hypovolemic shock and multi-organ failure and is characterized by hematologic abnormalities and vascular leak. At present, there are no approved vaccines or antiviral therapies to effectively prevent or treat VHF caused by pathogenic bunyaviruses. Advances in the modeling of bunyaviral infections have facilitated efforts towards the development of novel post-exposure prophylactic and therapeutic countermeasures, several of which may some day be approved for human use. Here, we review recent progress in animal models of severe bunyaviral infections essential to this mission, as well as promising antivirals and biologicals that are at various stages of the development process.

Citations

Citations to this article as recorded by  
  • Current insights into human pathogenic phenuiviruses and the host immune system
    Chuan-Min Zhou, Ze-Zheng Jiang, Ning Liu, Xue-Jie Yu
    Virulence.2024;[Epub]     CrossRef
  • Digoxin is a potent inhibitor of Bunyamwera virus infection in cell culture
    Beatriz Pacheco, Alberto Fernández-Oliva, Moisés García-Serradilla, Cristina Risco
    Journal of General Virology .2023;[Epub]     CrossRef
  • Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus
    Megan C. Mears, Sergio E. Rodriguez, Katharina S. Schmitz, Angel Padilla, Sudipta Biswas, Maria N.B. Cajimat, Chad E. Mire, Stephen R. Welch, Éric Bergeron, Christopher A. Alabi, Matteo Porotto, Dennis A. Bente
    Antiviral Research.2022; 207: 105401.     CrossRef
  • Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development
    Megan A. Files, Clairissa A. Hansen, Vanessa C. Herrera, Craig Schindewolf, Alan D. T. Barrett, David W. C. Beasley, Nigel Bourne, Gregg N. Milligan
    npj Vaccines.2022;[Epub]     CrossRef
  • Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections
    Valentijn Vergote, Lies Laenen, Raf Mols, Patrick Augustijns, Marc Van Ranst, Piet Maes
    Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
  • Light and electron microscopy imaging unveils new aspects of the antiviral capacity of silver nanoparticles in bunyavirus-infected cells
    Moisés García-Serradilla, Cristina Risco
    Virus Research.2021; 302: 198444.     CrossRef
  • Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection
    Mutsuyo Takayama-Ito, Masayuki Saijo
    Frontiers in Microbiology.2020;[Epub]     CrossRef
  • Multimeric single-domain antibody complexes protect against bunyavirus infections
    Paul J Wichgers Schreur, Sandra van de Water, Michiel Harmsen, Erick Bermúdez-Méndez, Dubravka Drabek, Frank Grosveld, Kerstin Wernike, Martin Beer, Andrea Aebischer, Olalekan Daramola, Sara Rodriguez Conde, Karen Brennan, Dorota Kozub, Maiken Søndergaard
    eLife.2020;[Epub]     CrossRef
  • Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
    Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Joan B. Geisbert, Krystle N. Agans, Daniel J. Deer, Karla A. Fenton, Thomas W. Geisbert, Waleed Saleh Al-Salem
    PLOS Neglected Tropical Diseases.2020; 14(8): e0008637.     CrossRef
  • High Prevalence of a Newly Discovered Wutai Mosquito Phasivirus in Mosquitoes from Rio de Janeiro, Brazil
    Mário Sérgio Ribeiro, Tania Ayllón, Viviana Malirat, Daniel Cardoso Portela Câmara, Cristina Maria Giordano Dias, Guilherme Louzada, Davis Fernandes-Ferreira, Roberto de Andrade Medronho, Renata Campos Acevedo
    Insects.2019; 10(5): 135.     CrossRef
  • Parallel Survey of Two Widespread Renal Syndrome-Causing Zoonoses:Leptospiraspp. andHantavirusin Urban Environment, Hungary
    Kornélia Kurucz, Mónika Madai, Dominika Bali, Dávid Hederics, Győző Horváth, Gábor Kemenesi, Ferenc Jakab
    Vector-Borne and Zoonotic Diseases.2018; 18(4): 200.     CrossRef
  • A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters
    Valentijn Vergote, Lies Laenen, Bert Vanmechelen, Marc Van Ranst, Erik Verbeken, Jay W. Hooper, Piet Maes, Michael R. Holbrook
    PLOS Neglected Tropical Diseases.2017; 11(10): e0006042.     CrossRef
Journal Article
MDA7/IL-24 is an anti-viral factor that inhibits influenza virus replication
Rak-Kyun Seong , Young-Ki Choi , Ok Sarah Shin
J. Microbiol. 2016;54(10):695-700.   Published online September 30, 2016
DOI: https://doi.org/10.1007/s12275-016-6383-2
  • 48 View
  • 0 Download
  • 13 Crossref
AbstractAbstract
Melanoma differentiation associated gene-7 (mda-7)/interleukin- 24 (IL-24) is a secreted cytokine, which plays an essential role in tumor suppression. Although its role as a multifunctional protein affecting broad types of cancers is well described, functions of IL-24 in host defense against virus infection are yet to be determined. In this study, we explored the anti-viral effect of recombinant IL-24 treatment during influenza infection. Infection of human lung adenocarcinoma cells (A549) with the influenza A virus up-regulated IL-24 mRNA and protein expression in a time-dependent manner. Pre-treatment of A549 cells with recombinant IL-24 protein effectively suppressed viral plaque formation. Furthermore, IL-24 treatment of A549 cells reduced viral non-structural protein 1 (NS1) synthesis, whereas IL-24 knockdown resulted in increased viral replication. Interestingly, IL-24 treatment following influenza A virus infection led to up-regulation of interferon (IFN)-induced antiviral signaling. Taken together, our results suggest that IL-24 exerts a potent suppressive effect on influenza viral replication and can be used in the treatment of influenza infection.

Citations

Citations to this article as recorded by  
  • Novel insight into MDA-7/IL-24: A potent therapeutic target for autoimmune and inflammatory diseases
    Kangni Feng, Jiemei Cen, Xiaoling Zou, Tiantuo Zhang
    Clinical Immunology.2024; 266: 110322.     CrossRef
  • Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Minqi Zhang, Haifeng Zhao, Honglei Gao
    Viral Immunology.2022; 35(3): 212.     CrossRef
  • Host–virus interaction and viral evasion
    Scheilla T. Strumillo, Denis Kartavykh, Fábio F. de Carvalho , Nicolly C. Cruz, Ana C. de Souza Teodoro, Ricardo Sobhie Diaz, Marli F. Curcio
    Cell Biology International.2021; 45(6): 1124.     CrossRef
  • SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response
    Soo Jin Oh, Ok Sarah Shin
    Cells.2021; 10(3): 530.     CrossRef
  • Interleukin-24 as a Pulmonary Target Cytokine in Bronchopulmonary Dysplasia
    Ruiwei Gao, Zhihua Li, Danyang Ai, Jinshuai Ma, Chao Chen, Xiuxiang Liu
    Cell Biochemistry and Biophysics.2021; 79(2): 311.     CrossRef
  • Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
    Chia-Jung Li, Yen-Dun Tony Tzeng, Yi-Han Chiu, Hung-Yu Lin, Ming-Feng Hou, Pei-Yi Chu
    Cancers.2021; 13(12): 2978.     CrossRef
  • MDA-7/interleukin 24 (IL-24) in tumor gene therapy: application of tumor penetrating/homing peptides for improvement of the effects
    Mohammad Rasoolian, Majid Kheirollahi, Seyed Younes Hosseini
    Expert Opinion on Biological Therapy.2019; 19(3): 211.     CrossRef
  • Alternative Experimental Models for Studying Influenza Proteins, Host–Virus Interactions and Anti-Influenza Drugs
    Sonja C. J. H. Chua, Hui Qing Tan, David Engelberg, Lina H. K. Lim
    Pharmaceuticals.2019; 12(4): 147.     CrossRef
  • HIV‐1 infection modulates IL‐24 expression which contributes to cell apoptosis in vitro
    Scheilla Teixeira Strumillo, Marli Ferreira Curcio, Fábio Ferreira de Carvalho, MariaCecília Araripe Sucupira, Ricardo Sobhie Diaz, Hugo Pequeno Monteiro, Luiz Mário Ramos Janini
    Cell Biology International.2019; 43(5): 574.     CrossRef
  • Production of Interleukin-20 cytokines limits bacterial clearance and lung inflammation during infection by Streptococcus pneumoniae
    Fahima Madouri, Olivia Barada, Gwenola Kervoaze, François Trottein, Muriel Pichavant, Philippe Gosset
    EBioMedicine.2018; 37: 417.     CrossRef
  • Inhibitory Effect and Mechanism of Mesenchymal Stem Cells Cultured in 3D System on Hepatoma Cells HepG2
    Diandian Zhao, Lingling Hou, Mengwu Pan, Jilei Hua, Ziling Wang, Jinsheng He, Honggang Hu
    Applied Biochemistry and Biotechnology.2018; 184(1): 212.     CrossRef
  • Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas
    Sangmin Kang, Jinjong Myoung
    Journal of Microbiology.2017; 55(5): 319.     CrossRef
  • Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication
    Rak-Kyun Seong, Seong-wook Seo, Ji-Ae Kim, Sarah J. Fletcher, Neil V. Morgan, Mukesh Kumar, Young-Ki Choi, Ok Sarah Shin
    Immunobiology.2017; 222(11): 979.     CrossRef
Review
MINIREVIEW] Multilayered regulations of RIG-I in the anti-viral signaling pathway
Nari Kim , Hesung Now , Nhung T.H. Nguyen , Joo-Yeon Yoo
J. Microbiol. 2016;54(9):583-587.   Published online August 31, 2016
DOI: https://doi.org/10.1007/s12275-016-6322-2
  • 46 View
  • 0 Download
  • 11 Crossref
AbstractAbstract
RIG-I is a cytosolic receptor recognizing virus-specific RNA structures and initiates an antiviral signaling that induces the production of interferons and proinflammatory cytokines. Because inappropriate RIG-I signaling affects either viral clearance or immune toxicity, multiple regulations of RIG-I have been investigated since its discovery as the viral RNA detector. In this review, we describe the recent progress in research on the regulation of RIG-I activity or abundance. Specifically, we focus on the mechanism that modulates RIGI- dependent antiviral response through post-translational modifications of or protein-protein interactions with RIG-I.

Citations

Citations to this article as recorded by  
  • Interferon-α stimulates DExH-box helicase 58 to prevent hepatocyte ferroptosis
    Kai-Wei Jia, Ren-Qi Yao, Yi-Wen Fan, Ding-Ji Zhang, Ye Zhou, Min-Jun Wang, Li-Yuan Zhang, Yue Dong, Zhi-Xuan Li, Su-Yuan Wang, Mu Wang, Yun-Hui Li, Lu-Xin Zhang, Ting Lei, Liang-Chen Gui, Shan Lu, Ying-Yun Yang, Si-Xian Wang, Yi-Zhi Yu, Yong-Ming Yao, Jin
    Military Medical Research.2024;[Epub]     CrossRef
  • ZNF205 positively regulates RLR antiviral signaling by targeting RIG-I
    Ni Zhong, Chen Wang, Guangxiu Weng, Ting Ling, Liangguo Xu
    Acta Biochimica et Biophysica Sinica.2023; 55(10): 1582.     CrossRef
  • Identification of Vital Hub Genes and Potential Molecular Pathways of Dermatomyositis by Bioinformatics Analysis
    Xueren Ouyang, Yuning Zeng, Xiaotao Jiang, Hua Xu, Yile Ning, Ming Yi
    BioMed Research International.2021; 2021: 1.     CrossRef
  • HSPBP1 facilitates cellular RLR-mediated antiviral response by inhibiting the K48-linked ubiquitination of RIG-I
    Ya-Xian Yang, Jing-Ping Huang, Sheng-Na Li, Jing Li, Ting Ling, Tao Xie, Liang-Guo Xu
    Molecular Immunology.2021; 134: 62.     CrossRef
  • Investigation of Human IFITM3 Polymorphisms rs34481144A and rs12252C and Risk for Influenza A(H1N1)pdm09 Severity in a Brazilian Cohort
    Jéssica S. C. Martins, Maria L. A. Oliveira, Cristiana C. Garcia, Marilda M. Siqueira, Aline R. Matos
    Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
  • Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses
    Thirupandiyur S. Udayakumar, Dillon M. Betancourt, Anis Ahmad, Wensi Tao, Tulasigeri M. Totiger, Mausam Patel, Brian Marples, Glen Barber, Alan Pollack
    Molecular Cancer Research.2020; 18(8): 1232.     CrossRef
  • Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
    Aline da Rocha Matos, Katharina Wunderlich, Sebastian Schloer, Klaus Schughart, Robert Geffers, Martine Seders, Marlous de Witt, Anmari Christersson, Rainer Wiewrodt, Karsten Wiebe, Peter Barth, Andreas Hocke, Stefan Hippenstiel, Katja Hönzke, Ulf Dittmer
    Emerging Microbes & Infections.2019; 8(1): 1763.     CrossRef
  • Discovery of Key Genes in Dermatomyositis Based on the Gene Expression Omnibus Database
    Shuoshan Xie, Hui Luo, Huali Zhang, Honglin Zhu, Xiaoxia Zuo, Sijia Liu
    DNA and Cell Biology.2018; 37(12): 982.     CrossRef
  • Change in the immune function of porcine iliac artery endothelial cells infected with porcine circovirus type 2 and its inhibition on monocyte derived dendritic cells maturation
    Ning Yang, Jinzeng Qiao, Shiyu Liu, Zhanming Zou, Linlin Zhu, Xinyu Liu, Shuanghai Zhou, Huanrong Li, Bernhard Ryffel
    PLOS ONE.2017; 12(10): e0186775.     CrossRef
  • Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas
    Sangmin Kang, Jinjong Myoung
    Journal of Microbiology.2017; 55(5): 319.     CrossRef
  • Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
    Armstrong Murira, Alain Lamarre
    Frontiers in Immunology.2016;[Epub]     CrossRef
Retracted Publication
Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components
Prasanna Weeratunga , Md Bashir Uddin , Myun Soo Kim , Byeong-Hoon Lee , Tae-Hwan Kim , Ji-Eun Yoon , Jin Yeul Ma , Hongik Kim , Jong-Soo Lee
J. Microbiol. 2016;54(1):57-70.   Published online January 5, 2016
DOI: https://doi.org/10.1007/s12275-016-5555-4
  • 47 View
  • 0 Download
  • 5 Crossref
AbstractAbstract
Angelica tenuissima Nakai is a widely used commodity in traditional medicine. Nevertheless, no study has been conducted on the antiviral and immune-modulatory properties of an aqueous extract of Angelica tenuissima Nakai. In the present study, we evaluated the antiviral activities and the mechanism of action of an aqueous extract of Angelica tenuissima Nakai both in vitro and in vivo. In vitro, an effective dose of Angelica tenuissima Nakai markedly inhibited the replication of Influenza A virus (PR8), Vesicular stomatitis virus (VSV), Herpes simplex virus (HSV), Coxsackie virus, and Enterovirus (EV-71) on epithelial (HEK293T/HeLa) and immune (RAW264.7) cells. Such inhibition can be described by the induction of the antiviral state in cells by antiviral, IFNrelated gene induction and secretion of IFNs and pro-inflammatory cytokines. In vivo, Angelica tenuissima Nakai treated BALB/c mice displayed higher survivability and lower lung viral titers when challenged with lethal doses of highly pathogenic influenza A subtypes (H1N1, H5N2, H7N3, and H9N2). We also found that Angelica tenuissima Nakai can induce the secretion of IL-6, IFN-λ, and local IgA in bronchoalveolar lavage fluid (BALF) of Angelica tenuissima Nakai treated mice, which correlating with the observed prophylactic effects. In HPLC analysis, we found the presence of several compounds in the aqueous fraction and among them; we evaluated antiviral properties of ferulic acid. Therefore, an extract of Angelica tenuissima Nakai and its components, including ferulic acid, play roles as immunomodulators and may be potential candidates for novel anti-viral/anti-influenza agents.

Citations

Citations to this article as recorded by  
  • The stimulatory effect of Angelica tenuissima Nakai in osteoblastic/odontoblastic differentiation of human periodontal ligament stem cells
    Won-Jong Park, Youn Ho Han
    Korean Journal of Dental Materials.2022; 49(4): 187.     CrossRef
  • Fermented Angelicae tenussimae with Aspergillus oryzae Improves Skin Barrier Properties, Moisturizing, and Anti-Inflammatory Responses
    Chang-Woo Ha, Eun-Hwa Sohn, Sung-Hyeok Kim, Sohee Jang, Myung-Rye Park, Youn-Kyu Kim, In-Young Bae
    International Journal of Molecular Sciences.2022; 23(20): 12072.     CrossRef
  • Extract of Polygala tenuifolia, Angelica tenuissima, and Dimocarpus longan Reduces Behavioral Defect and Enhances Autophagy in Experimental Models of Parkinson’s Disease
    Huan Li, Joonki Kim, Huynh Nguyen Khanh Tran, Chang Hwan Lee, Jonghyun Hur, Min Cheol Kim, Hyun Ok Yang
    NeuroMolecular Medicine.2021; 23(3): 428.     CrossRef
  • Chemical Constituents of the Root of Angelica tenuissima and their Anti-allergic Inflammatory Activity
    Hyun Gyu Choi, In-Gyu Je, Geum Jin Kim, Joo-Won Nam, Sang Hee Shim, Sang-Hyun Kim, Hyukjae Choi
    Natural Product Communications.2017;[Epub]     CrossRef
  • Inhibitory effects of bee venom and its components against viruses in vitro and in vivo
    Md Bashir Uddin, Byeong-Hoon Lee, Chamilani Nikapitiya, Jae-Hoon Kim, Tae-Hwan Kim, Hyun-Cheol Lee, Choul Goo Kim, Jong-Soo Lee, Chul-Joong Kim
    Journal of Microbiology.2016; 54(12): 853.     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP